Health officials investigating whether vaccine causes blood clots
Health Canada is keeping tabs on European investigations into the Oxford-AstraZeneca vaccine after overseas reports of some recipients developing blood clots following inoculations.
For now, the government agency is assuring Canadians that the ''benefits of the vaccine continue to outweigh its risks.''
It says it authorized the vaccine for Canadian use based on a thorough review.
At least nine European countries as well as, Thailand, have temporarily suspended their use of AstraZeneca's doses pending investigation of blood clots, though none suggest there is a link between the two.
Temporary Patio Program Turned Down
Port Colborne Trying to Reduce Water Rates
Province Supporting Niagara Festivals
2nd Suspect Arrested in Vape Store Theft
Man Charged with Sexual Assault
Public Health Asking for $42-Mill
Fort Erie Increasing Pressure on Niagara Health
150th Birthday Celebrated at Montebello Park